Developed in conjunction with

June, 2014
SOM Biotech will attend next BIO International Convention through its Canadian partner Willow Tree Capital Group...
April, 2014
SOM Biotech and The Vall d'Hebron Institute of...

September, 2012

A recent Thomson Reuters report indicates that drug repositioning is expected to generate up to $20Billion in annual sales during 2012, thus opening up a new source of revenue to large, medium and small Pharma companies.